The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial
- 14 March 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (8), 3701-3711
- https://doi.org/10.1039/d3fo00167a
Abstract
Introduction: different lines of evidence have shown that ginger administration may be beneficial for patients with multiple sclerosis (MS). Therefore, we aimed to investigate the effect of ginger supplementation on disability, physical and psychological quality of life (QoL), body mass index (BMI), neurofilament light chain (NfL), interlukin-17 (IL-17), matrix metalloproteinase-9 (MMP-9), and neutrophil to lymphocyte ratio (NLR) in patients with relapsing-remitting MS. Methods: this was a 12 week double-blind parallel randomized placebo-controlled trial with a 3 week run-in period. The treatment (n = 26) and control (n = 26) groups received 500 mg ginger and placebo (corn) supplements 3 times daily, respectively. Disability was evaluated using the Expanded Disability Status Scale (EDSS). QoL was rated using the Multiple Sclerosis Impact Scale (MSIS-29). BMI was calculated by dividing weight by height squared. Serum levels of NfL, IL-17, and MMP-9 were measured using the enzyme-linked immunosorbent assay. NLR was determined using a Sysmex XP-300™ automated hematology analyzer. All outcomes were assessed before and after the intervention and analyzed using the intention-to-treat principle. Results: in comparison with placebo, ginger supplementation caused a significant reduction in the EDSS (−0.54 ± 0.58 vs. 0.08 ± 0.23, P < 0.001), the MSIS-29 physical scale (−8.15 ± 15.75 vs. 4.23 ± 8.46, P = 0.001), the MSIS-29 psychological scale (−15.71 ± 19.59 vs. 6.68 ± 10.41, P < 0.001), NfL (−0.14 ± 0.97 vs. 0.38 ± 1.06 ng mL−1, P = 0.049), IL-17 (−3.34 ± 4.06 vs. 1.77 ± 6.51 ng L−1, P = 0.003), and NLR (−0.09 ± 0.53 vs. 0.53 ± 1.90, P = 0.038). Nevertheless, the differences in BMI and MMP-9 were not significant between the groups. Conclusion: ginger supplementation may be an effective adjuvant therapy for patients with relapsing-remitting MS.Funding Information
- Isfahan University of Medical Sciences (3400357)
This publication has 73 references indexed in Scilit:
- Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overviewActa Neurologica Belgica, 2013
- 6‐Shogaol inhibits chondrocytes’ innate immune responses and cathepsin‐K activityMolecular Nutrition & Food Research, 2013
- Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patientsInternational Journal of Food Sciences and Nutrition, 2013
- Synergistic activity of interleukin-17 and tumor necrosis factor-α enhances oxidative stress-mediated oligodendrocyte apoptosisJournal of Neurochemistry, 2010
- Anti‐invasion effects of 6‐shogaol and 6‐gingerol, two active components in ginger, on human hepatocarcinoma cellsMolecular Nutrition & Food Research, 2010
- 6‐Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase‐9 expression via blockade of nuclear factor‐κB activationBritish Journal of Pharmacology, 2010
- [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cellsThe Journal of Nutritional Biochemistry, 2008
- The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)Journal of Neurology, Neurosurgery & Psychiatry, 2007
- Analysis of Data with Imbalance in the Baseline Outcome Variable for Randomized Clinical TrialsDrug Information Journal, 2001
- Rating neurologic impairment in multiple sclerosisNeurology, 1983